Olin and Huntsman merger clears review

• Olin (NYSE:OLN) and Huntsman (NYSE:HUN) cleared the U.S. antitrust waiting period for their proposed merger of equals.
• The milestone satisfies one closing condition for the pending transaction.
• The merger still requires additional regulatory approvals and customary closing conditions.

Olin (NYSE:OLN) and Huntsman (NYSE:HUN) announced that the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act for their proposed merger of equals has expired.

The expiration removes one regulatory requirement for the transaction after shareholders of both companies approved the merger on August 25, 2026.

The transaction remains subject to additional regulatory approvals and other customary closing conditions before completion.

Olin operates as a vertically integrated global chemical manufacturer and is also a U.S. ammunition producer, while Huntsman is a diversified chemicals company.

Huntsman reported approximately $6 billion in 2025 revenue from continuing operations, with more than 55 facilities across about 25 countries and approximately 6,000 employees.